A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
Recruiting · NCT05563766 · Registry updated 2026-10-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal adenocarcinoma, esophageal disorder, esophageal squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasm | Recruiting | Phase 2 | 2026-10-09 | NCT05563766 |
9 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Durham VA Medical Center, Durham, NC | Durham | United States | 34 |
| Michael E. DeBakey VA Medical Center, Houston, TX | Houston | United States | 30 |
| VA Ann Arbor Healthcare System, Ann Arbor, MI | Ann Arbor | United States | 24 |
| VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX | Dallas | United States | 22 |
| VA Palo Alto Health Care System, Palo Alto, CA | Palo Alto | United States | 34 |
| VA Portland Health Care System, Portland, OR | Portland | United States | 30 |
| VA Puget Sound Health Care System Seattle Division, Seattle, WA | Seattle | United States | 32 |